Reprint of: From the 90׳s to now: A brief historical perspective on more than two decades of estrogen neuroprotection

@article{EnglerChiurazzi2016ReprintOF,
  title={Reprint of: From the 90׳s to now: A brief historical perspective on more than two decades of estrogen neuroprotection},
  author={Elizabeth B. Engler-Chiurazzi and Mahendra Singh and James W. Simpkins},
  journal={Brain research},
  year={2016},
  volume={1645},
  pages={
          79-82
        }
}
UNLABELLED Historical perspective abstract:From the 90׳s to now: a historical perspective on more than two decades of estrogen neuroprotection: In the early 90׳s, estrogens were known to exert organizational and activational effects on reproductive tissues and sexual behavior. As well, the role of sex and gonadal hormones in altering the risk for developing Alzheimer׳s Disease (AD) was only beginning to be elucidated. Preliminary investigations suggested that estrogen-containing therapies… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Novel Therapeutics in Glaucoma Management

  • Current neuropharmacology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Estrogens and neuroprotectants: estrogenic actions in the context of cognitive aging and brain injury

Engler-Chiurazzi, E.B
  • 2016

Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study

Gleason, C.E
  • PLoS Med
  • 2015

Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.

  • Climacteric : the journal of the International Menopause Society
  • 2012
VIEW 1 EXCERPT